Workflow
杀菌剂
icon
Search documents
润丰股份10月9日获融资买入1052.12万元,融资余额2.04亿元
Xin Lang Cai Jing· 2025-10-10 01:30
10月9日,润丰股份跌0.16%,成交额1.70亿元。两融数据显示,当日润丰股份获融资买入额1052.12万 元,融资偿还944.60万元,融资净买入107.52万元。截至10月9日,润丰股份融资融券余额合计2.05亿 元。 融资方面,润丰股份当日融资买入1052.12万元。当前融资余额2.04亿元,占流通市值的0.91%,融资余 额超过近一年80%分位水平,处于高位。 融券方面,润丰股份10月9日融券偿还0.00股,融券卖出4600.00股,按当日收盘价计算,卖出金额36.68 万元;融券余量1.62万股,融券余额129.16万元,超过近一年60%分位水平,处于较高位。 资料显示,山东潍坊润丰化工股份有限公司位于山东省济南市高新区汉峪金融商务中心五区5号楼 3001,成立日期2005年6月23日,上市日期2021年7月28日,公司主营业务涉及农药原药及制剂的研发、 生产和销售。主营业务收入构成为:除草剂72.04%,杀虫剂16.26%,杀菌剂10.33%,其他1.14%,其他 (补充)0.22%。 截至6月30日,润丰股份股东户数6828.00,较上期增加22.12%;人均流通股41058股,较上期减少 1 ...
国光股份:植物生长调节剂与其他农药的主要区别
Zheng Quan Ri Bao· 2025-10-09 08:40
证券日报网讯国光股份10月9日发布公告,在公司回答调研者提问时表示,植物生长调节剂,又称植调 剂,是根据植物内源激素的结构、功能和作用原理,经过人工提取、合成的,能够调节植物生长发育和 生理功能的化学物质,对植物的生长发育起到与内源激素相同的调节、控制以及诱导作用。在农药类别 中,植调剂是较特殊的一种。植调剂的"用量低、效果显著、投入产出比高"这一优势,使得该类农药成 为现代农业不可或缺的重要生产资料。植调剂与其他农药(除草剂、杀虫剂、杀菌剂等)的主要区别如 下:(1)从功效作用上来说:植物生长调节剂主要用于调控植物自身的生长发育过程,如促进或抑制 细胞分裂、伸长,调节开花、结果、成熟等生理活动,从而达到提高作物产量、改善品质、增强抗逆性 等目的。其他农药主要针对植物病虫害或杂草等有害生物,通过杀灭、抑制或驱赶等方式保护作物免受 侵害,维持作物正常生长,例如:杀虫剂用于防治害虫,杀菌剂用于防治病菌,除草剂用于清除杂草。 (2)从生产工艺来看:植物生长调节剂原药多为化学合成或生物转化,工艺流程相对固定、简单,工 艺路线较短。此外,植物生长调节剂原药原材料广泛,市场供应与价格相对稳定。(3)从行业发展阶 段来看: ...
盘中必读|固态电池又迎来新突破!板块强势拉升,丰山集团等多股涨停
Xin Lang Cai Jing· 2025-09-29 04:55
9月29日,固态电池概念活跃,丰山集团、湘潭电化、万向钱潮等多股涨停,佛塑科技、赢合科技(维权)、德尔股份 等跟涨。 丰山集团(603810),涨停价:15.71元/股,市盈率:42.82,总市值:25.96亿。 【异动原因:清华大学化工系教授张强领衔的团队在锂电池聚合物电解质研究领域取得重要进展】 9月29日,A股市场固态电池板块表现强势,截止午市收盘,万润新能20CM涨停领涨板块,丰山集团、湘潭电化、万向 钱潮、石大胜华、芳源股份等多股相继封板。天奈科技、湖南裕能、力王股份等涨超10%,固态电池板块整体涨幅近 3%,显著跑赢大盘。 在传统业务企稳的同时,丰山集团正加速向新能源领域渗透,尤其在固态电池赛道的布局已实现技术卡位。旗下子公司 丰山全诺新能源科技有限公司,目前聚焦电解液与固态材料研发。丰山全诺一期5万吨电池电解液项目已正式投产,并 于2025年7月取得《安全生产许可证》,具备向动力电池企业批量供货的资质。 【板块涨停个股】 MACD金叉信号形成,这些股涨势不错! 涨停个股中丰山集团值得一提。作为一家深耕农药领域多年的化工企业,丰山集团的主营业务是农药,其中传统农药业 务仍是营收基本盘;核心产品涵盖 ...
上纬新材再涨超44%;最熊股博瑞医药周跌超38%丨透视一周牛熊股
Market Performance - The A-share market indices collectively rose during the week of September 22 to September 26, with the Shanghai Composite Index closing at 3828.11 points, up 0.21% for the week [1] - The Shenzhen Component Index closed at 13209.00 points, up 1.06%, while the ChiNext Index closed at 3151.53 points, up 1.96% [1] - Over 30% of stocks experienced gains, with 126 stocks rising over 15% and 50 stocks declining over 15% [1] Top Gainers - Bluefeng Biochemical (002513.SZ) led the gainers with a weekly increase of 61.16%, followed by Sunflower (300111.SZ) with a 57.86% rise [2] - Other notable gainers included Jucheng Technology (688123.SH), Changchuan Technology (300604.SZ), and Fuke Environmental Protection (688335.SH), all with gains exceeding 44% [2] - Bluefeng Biochemical is a major domestic producer of pesticides, and it recently established a subsidiary focused on high-efficiency N-type crystalline silicon photovoltaic products [2][3] Top Losers - Borui Pharmaceutical (688166.SH) was the biggest loser, with a decline of 38.36% [5] - Other significant decliners included Xiangjiang Holdings (600162.SH) and Haotaitai (603848.SH), both with declines over 22% [5] - Borui Pharmaceutical's stock price fell to 58.06 yuan per share, with a 12.57% drop on September 26 alone [6] Company Developments - Borui Pharmaceutical announced a stock repurchase plan, proposing to buy back shares worth between 10 million and 20 million yuan [9] - The company is progressing with its overseas market expansion, with several clinical trials ongoing for its weight loss products in the U.S. [8][9] - Pfizer's acquisition of Metsera for $7.3 billion has impacted Borui Pharmaceutical's stock, signaling a shift in market expectations for weight loss drug development [10]
农心科技涨2.05%,成交额1005.95万元
Xin Lang Cai Jing· 2025-09-26 02:33
分红方面,农心科技A股上市后累计派现4777.94万元。 机构持仓方面,截止2025年6月30日,农心科技十大流通股东中,诺安多策略混合A(320016)位居第 五大流通股东,持股49.03万股,为新进股东。 责任编辑:小浪快报 9月26日,农心科技盘中上涨2.05%,截至10:16,报20.37元/股,成交1005.95万元,换手率1.01%,总市 值20.37亿元。 农心科技今年以来股价涨23.16%,近5个交易日跌0.59%,近20日跌0.24%,近60日涨3.24%。 资料显示,农心作物科技股份有限公司位于陕西省西安市高新区沣惠南路36号橡树街区B楼11803室, 成立日期2006年6月7日,上市日期2022年8月19日,公司主营业务涉及农药制剂产品的研发、生产与销 售。主营业务收入构成为:杀虫剂46.76%,杀菌剂30.49%,除草剂13.16%,其他9.59%。 农心科技所属申万行业为:基础化工-农化制品-农药。所属概念板块包括:微盘股、小盘、生物农药、 QFII持股等。 截至9月19日,农心科技股东户数9069.00,较上期减少3.98%;人均流通股5502股,较上期增加4.15%。 2025年 ...
安道麦A跌2.15%,成交额1285.52万元
Xin Lang Cai Jing· 2025-09-25 05:32
Core Viewpoint - The stock price of Andermatt A has experienced a decline of 4.64% year-to-date, with significant drops over various trading periods, indicating potential challenges in the company's market performance [1]. Company Overview - Andermatt A, established on March 27, 1998, and listed on December 3, 1993, is located at 93 Beijing East Road, Jingzhou, Hubei Province. The company specializes in the research, production, and sales of pesticide raw materials and intermediates [1]. - The main revenue composition includes herbicides (43.89%), insecticides (26.05%), fungicides (20.96%), and fine chemical products (non-agricultural) (9.10%) [1]. Financial Performance - For the first half of 2025, Andermatt A reported a revenue of 15.024 billion yuan, reflecting a year-on-year growth of 0.76%. However, the net profit attributable to shareholders was a loss of 80.352 million yuan, which is a significant improvement with a year-on-year increase of 91.02% [1]. Shareholder Information - As of June 30, 2025, the number of shareholders for Andermatt A was 37,600, a decrease of 8.89% from the previous period. The average circulating shares per person increased by 13.72% to 83,982 shares [1]. - The company has distributed a total of 9.64 billion yuan in dividends since its listing, with 62.904 million yuan distributed over the past three years [2]. Institutional Holdings - As of June 30, 2025, Hong Kong Central Clearing Limited was the fourth-largest circulating shareholder of Andermatt A, holding 18.2916 million shares, an increase of 10.5967 million shares from the previous period [2].
百傲化学上半年净利同比下降
Zhong Guo Hua Gong Bao· 2025-09-23 02:38
Core Viewpoint - Dalian Baiao Chemical Co., Ltd. reported a revenue of 749 million yuan for the first half of 2025, marking a year-on-year increase of 28.42%, while net profit decreased by 44.22% to 91.79 million yuan [1] Group 1: Financial Performance - The company achieved a revenue of 749 million yuan, reflecting a growth of 28.42% compared to the previous year [1] - Net profit for the first half of the year was 91.79 million yuan, which represents a decline of 44.22% year-on-year [1] Group 2: Business Segments - Baiao Chemical has established a dual business model focusing on industrial biocides and semiconductor equipment [1] - The chemical business is facing challenges due to external environmental factors, weak market demand, and continuously low prices, leading to sustained pressure on profitability [1] - The semiconductor business is part of a long-term strategic plan aimed at technology accumulation and building a competitive advantage [1] Group 3: Market Trends - Despite the overall pressure on the biocide business, positive changes are emerging, with the average sales price of biocide products increasing by 7.69% quarter-on-quarter [1] - The comprehensive procurement cost of key raw materials, including n-octylamine, methyl acrylate, magnesium nitrate, ethyl acetate, and chlorine, decreased by 21.37% quarter-on-quarter [1] - The gross margin of the industrial biocide business is expected to improve on a quarter-on-quarter basis [1]
农心科技股价跌5.2%,诺安基金旗下1只基金位居十大流通股东,持有49.03万股浮亏损失51.48万元
Xin Lang Cai Jing· 2025-09-23 02:35
Group 1 - The core point of the news is that Nongxin Technology's stock price dropped by 5.2% to 19.15 yuan per share, with a total market value of 1.915 billion yuan as of the report date [1] - Nongxin Technology, established on June 7, 2006, specializes in the research, production, and sales of pesticide formulations, with its main revenue sources being insecticides (46.76%), fungicides (30.49%), herbicides (13.16%), and others (9.59%) [1] Group 2 - Among the top circulating shareholders of Nongxin Technology, the Nuoan Multi-Strategy Mixed A Fund (320016) entered the top ten in the second quarter, holding 490,300 shares, which accounts for 1.38% of the circulating shares [2] - The Nuoan Multi-Strategy Mixed A Fund has a total scale of 1.399 billion yuan and has achieved a year-to-date return of 57.56%, ranking 694 out of 8172 in its category [2] Group 3 - The fund managers of Nuoan Multi-Strategy Mixed A are Kong Xianzheng and Wang Haichang, with Kong having a tenure of 4 years and 302 days and a total fund size of 4.607 billion yuan, achieving a best return of 72.6% during his tenure [3] - Wang has a tenure of 3 years and 64 days with a fund size of 2.529 billion yuan, achieving a best return of 60.45% during his tenure [3]
泰禾股份9月18日获融资买入992.89万元,融资余额8015.53万元
Xin Lang Cai Jing· 2025-09-19 01:39
Group 1 - The core viewpoint of the news is that Taihe Co., Ltd. has shown fluctuations in stock performance and financing activities, with a notable decrease in stock price and mixed financing data [1][2] - As of September 18, Taihe's stock price dropped by 1.77%, with a trading volume of 95.71 million yuan, and a net financing outflow of 1.42 million yuan [1] - The company's financing balance is 80.16 million yuan, accounting for 7.45% of its market capitalization [1] Group 2 - For the first half of 2025, Taihe reported a revenue of 2.413 billion yuan, representing a year-on-year growth of 23.15%, and a net profit attributable to shareholders of 182 million yuan, up 72.20% year-on-year [2] - The company has distributed a total of 270 million yuan in dividends since its A-share listing [3] - As of June 30, 2025, the second-largest shareholder is Hong Kong Central Clearing Limited, holding 401,900 shares as a new shareholder [3]
泰禾股份9月17日获融资买入2284.19万元,融资余额8157.72万元
Xin Lang Cai Jing· 2025-09-18 01:46
Group 1 - The core viewpoint of the news is that Taihe Co., Ltd. has shown positive financial performance with significant growth in revenue and net profit for the first half of 2025, alongside active trading in its stock [1][2]. - On September 17, 2023, Taihe Co., Ltd. experienced a stock price increase of 0.63% with a trading volume of 109 million yuan, and a net financing purchase of 15.4 million yuan [1]. - As of September 17, 2023, the total balance of margin trading for Taihe Co., Ltd. was 81.58 million yuan, accounting for 7.45% of its circulating market value [1]. Group 2 - For the first half of 2025, Taihe Co., Ltd. achieved an operating income of 2.413 billion yuan, representing a year-on-year growth of 23.15%, and a net profit attributable to shareholders of 182 million yuan, with a year-on-year increase of 72.20% [1]. - The company has distributed a total of 270 million yuan in dividends since its A-share listing [2]. - As of June 30, 2025, Hong Kong Central Clearing Limited became the second-largest circulating shareholder of Taihe Co., Ltd., holding 401,900 shares as a new shareholder [2].